Aldehyde dehydrogenase-bright cells correlated with the colony-forming unit-granulocyte-macrophage assay of thawed cord blood units

Transfusion

Volumn 54, Issue 7, 2014, Pages 1871-1875

  Lee, Hye Ryun ^a   Shin, Sue ^b,c   Yoon, Jong Hyun ^b,c   Roh, Eun Youn ^b,c   Kim, Byoung Jae ^d   Song, Eun Young ^b  

^a Gyeongsang National University   (South Korea)

^b Seoul National University   (South Korea)

^c Seoul National University Boramae Hospital   (South Korea)

^d Seoul National University Boramae Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE DEHYDROGENASE BRIGHT CELL; ARTICLE; CELL ASSAY; COLONY FORMING UNIT GEMM; COLONY FORMING UNIT GM; COLONY FORMING UNIT GRANULOCYTE MACROPHAGE ASSAY; CONTROLLED STUDY; CRYOPRESERVATION; HEMATOPOIETIC STEM CELL; QUALITY CONTROL; THAWING; UMBILICAL CORD BLOOD;

ALDEHYDE DEHYDROGENASE; BIOLOGICAL MARKERS; BLOOD CELL COUNT; BLOOD PRESERVATION; COLONY-FORMING UNITS ASSAY; CORD BLOOD STEM CELL TRANSPLANTATION; CRYOPRESERVATION; FETAL BLOOD; FREEZING; GRANULOCYTE-MACROPHAGE PROGENITOR CELLS; HEMATOPOIETIC STEM CELLS; HUMANS;

EID: 84904472962     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12555     Document Type: Article

References (32)

1. Rubinstein P, Carrier C, Scaradavou A, et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 1998; 339: 1565-1577.
2. Gluckman E, Rocha V, Boyer-Chammard A, et al. Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. N Engl J Med 1997; 337: 373-381.
3. Gluckman E, Broxmeyer HA, Auerbach AD, et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med 1989; 321: 1174-1178.
4. Ballen K, Broxmeyer HE, McCullough J, et al. Current status of cord blood banking and transplantation in the United States and Europe. Biol Blood Marrow Transplant 2001; 7: 635-645.
5. Wagner JE, Barker JN, DeFor TE, et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 2002; 100: 1611-1618.
6. Schmitz N, Barrett J,. Optimizing engraftment-source and dose of stem cells. Semin Hematol 2002; 39: 3-14.
7. Migliaccio AR, Adamson JW, Stevens CE, et al. Cell dose and speed of engraftment in placental/umbilical cord blood transplantation: graft progenitor cell content is a better predictor than nucleated cell quantity. Blood 2000; 96: 2717-2722.
8. Bhatia M, Bonnet D, Murdoch B, et al. A newly discovered class of human hematopoietic cells with SCID-repopulating activity. Nat Med 1998; 4: 1038-1045.
9. Dao MA, Arevalo J, Nolta JA,. Reversibility of CD34 expression on human hematopoietic stem cells that retain the capacity for secondary reconstitution. Blood 2003; 101: 112-118.
10. Balber AE,. Concise review: aldehyde dehydrogenase bright stem and progenitor cell populations from normal tissues: characteristics, activities, and emerging uses in regenerative medicine. Stem Cells 2011; 29: 570-575.
11. Hess DA, Wirthlin L, Craft TP, et al. Selection based on CD133 and high aldehyde dehydrogenase activity isolates long-term reconstituting human hematopoietic stem cells. Blood 2006; 107: 2162-2169.
12. Storms RW, Green PD, Safford KM, et al. Distinct hematopoietic progenitor compartments are delineated by the expression of aldehyde dehydrogenase and CD34. Blood 2005; 106: 95-102.
13. Pamphilon D, Selogie E, McKenna D, et al. Current practices and prospects for standardization of the hematopoietic colony-forming unit assay: a report by the cellular therapy team of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative. Cytotherapy 2013; 15: 255-262.
14. Nawrot M, McKenna DH, Sumstad D, et al. Interlaboratory assessment of a novel colony-forming unit assay: a multicenter study by the cellular team of Biomedical Excellence for Safer Transfusion (BEST) collaborative. Transfusion 2011; 51: 2001-2005.
15. Davis-Sproul J, Haley NR, McMannis JD,. Collecting and processing marrow products for transplantation. In:, Roback JD, Grossman BJ, Harris T, et al., editors. Technical manual. 17th ed. Bethesda, MD: American Association of Blood Banks; 2011. p. 792-794.
16. Kang HJ, Yoo KH, Lee JW, et al. Double umbilical cord blood transplantation for children and adolescents. Ann Hematol 2010; 89: 1035-1044.
17. Lee HR, Park JS, Shin S, et al. Increased numbers of total nucleated and CD34+ cells in blood group O cord blood: an analysis of neonatal innate factors in the Korean population. Transfusion 2012; 52: 76-81.
18. Kurtzberg J, Laughlin M, Graham ML, et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med 1996; 335: 157-166.
19. Hess DA, Meyerrose TE, Wirthlin L, et al. Functional characterization of highly purified human hematopoietic repopulating cells isolated according to aldehyde dehydrogenase activity. Blood 2004; 104: 1648-1655.
20. Prasad VK, Mendizabal A, Parikh SH, et al. Unrelated donor umbilical cord blood transplantation for inherited metabolic disorders in 159 pediatric patients from a single center: influence of cellular composition of the graft on transplantation outcomes. Blood 2008; 112: 2979-2989.
21. Emminger W, Emminger-Schmidmeier W, Hocker P, et al. Myeloid progenitor cells (CFU-GM) predict engraftment kinetics in autologous transplantation in children. Bone Marrow Transplant 1989; 4: 415-420.
22. al-Fiar F, Prince HM, Imrie K, et al. Bone marrow mononuclear cell count does not predict neutrophil and platelet recovery following autologous bone marrow transplant: value of the colony-forming unit granulocyte-macrophage (CFU-GM) assay. Cell Transplant 1997; 6: 491-495.
23. Douay L, Gorin NC, Mary JY, et al. Recovery of CFU-GM from cryopreserved marrow and in vivo evaluation after autologous bone marrow transplantation are predictive of engraftment. Exp Hematol 1986; 14: 358-365.
24. Lee YH, Cho NC, Je KH, et al. Successful sibling cord blood stem cell transplantation for relapsed acute mixed lineage leukemia. Korean J Hematol 1999; 34: 471-476.
25. Yoo KH, Lee SH, Kim HJ, et al. The impact of post-thaw colony-forming units-granulocyte/macrophage on engraftment following unrelated cord blood transplantation in pediatric recipients. Bone Marrow Transplant 2007; 39: 515-521.
26. Serke S, Arseniev L, Watts M, et al. Imprecision of counting CFU-GM colonies and CD34-expressing cells. Bone Marrow Transplant 1997; 20: 57-61.
27. Spellman S, Hurley CK, Brady C, et al. Guidelines for the development and validation of new potency assays for the evaluation of umbilical cord blood. Cytotherapy 2011; 13: 848-855.
28. Vasiliou V, Thompson DC, Smith C, et al. Aldehyde dehydrogenases: from eye crystallins to metabolic disease and cancer stem cells. Chem Biol Interact 2013; 202: 2-10.
29. Koppaka V, Thompson DC, Chen Y, et al. Aldehyde dehydrogenase inhibitors: a comprehensive review of the pharmacology, mechanism of action, substrate specificity, and clinical application. Pharmacol Rev 2012; 64: 520-539.
30. Storms RW, Trujillo AP, Springer JB, et al. Isolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activity. Proc Natl Acad Sci U S A 1999; 96: 9118-9123.
31. Gentry T, Deibert E, Foster SJ, et al. Isolation of early hematopoietic cells, including megakaryocyte progenitors, in the ALDH-bright cell population of cryopreserved, banked UC blood. Cytotherapy 2007; 9: 569-576.
32. Page KM, Zhang L, Mendizabal A, et al. The Cord Blood Apgar: a novel scoring system to optimize selection of banked cord blood grafts for transplantation (CME). Transfusion 2012; 52: 272-283.